A barrel of monkeys: scAAV8 gene therapy for hemophilia in nonhuman primates.
作者信息
Chandler Randy J, Venditti Charles P
机构信息
Organic Acid Research Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20893, USA.
出版信息
Mol Ther. 2011 May;19(5):826-7. doi: 10.1038/mt.2011.73.
Abstract
摘要
相似文献
1
A barrel of monkeys: scAAV8 gene therapy for hemophilia in nonhuman primates.
Mol Ther. 2011 May;19(5):826-7. doi: 10.1038/mt.2011.73.
2
Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.
Hum Gene Ther. 2015 Feb;26(2):69-81. doi: 10.1089/hum.2014.106. Epub 2015 Jan 21.
3
Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.
Mol Ther. 2011 May;19(5):876-85. doi: 10.1038/mt.2010.274. Epub 2011 Jan 18.
4
Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog model.
Blood Adv. 2018 Mar 13;2(5):505-508. doi: 10.1182/bloodadvances.2017015313.
5
Gene therapy for hemophilia: advancing beyond the first clinical success.
Curr Opin Hematol. 2013 Sep;20(5):410-6. doi: 10.1097/MOH.0b013e328363c1a1.
6
Gene therapy, an ongoing revolution.
Blood. 2012 Mar 29;119(13):2973-4. doi: 10.1182/blood-2012-02-409086.
7
Gene therapy for hemophilia B mice with scAAV8-LP1-hFIX.
Front Med. 2016 Jun;10(2):212-8. doi: 10.1007/s11684-016-0438-y. Epub 2016 Apr 6.
8
Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy.
Blood. 2005 Apr 15;105(8):3079-86. doi: 10.1182/blood-2004-10-3867. Epub 2005 Jan 6.
9
Hemophilia Gene Therapy: Caught Between a Cure and an Immune Response.
Mol Ther. 2015 Sep;23(9):1411-2. doi: 10.1038/mt.2015.135.
10
Recombinant adeno-associated virus delivers human factor IX in mice.
Mol Med Today. 1997 Sep;3(9):368. doi: 10.1016/s1357-4310(97)73461-0.
引用本文的文献
1
Mini-review on "A novel one-step purification of mouse factor IX".
J Rare Dis Res Treat. 2016;1(2):8-10.
2
Minimizing the inhibitory effect of neutralizing antibody for efficient gene expression in the liver with adeno-associated virus 8 vectors.
Mol Ther. 2013 Feb;21(2):318-23. doi: 10.1038/mt.2012.258. Epub 2012 Dec 18.
本文引用的文献
1
Hemophilia gene therapy: a Holy Grail found.
Mol Ther. 2011 Mar;19(3):427-8. doi: 10.1038/mt.2011.13.
2
Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.
Mol Ther. 2011 May;19(5):876-85. doi: 10.1038/mt.2010.274. Epub 2011 Jan 18.
3
The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques.
Mol Ther. 2010 Jan;18(1):126-34. doi: 10.1038/mt.2009.245. Epub 2009 Nov 3.
4
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16363-8. doi: 10.1073/pnas.0904514106. Epub 2009 Aug 12.
5
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.
Blood. 2009 Sep 3;114(10):2077-86. doi: 10.1182/blood-2008-07-167510. Epub 2009 Jun 8.
6
Gene therapy for haemophilia.
Br J Haematol. 2008 Mar;140(5):479-87. doi: 10.1111/j.1365-2141.2007.06942.x.
7
AAV vector integration sites in mouse hepatocellular carcinoma.
Science. 2007 Jul 27;317(5837):477. doi: 10.1126/science.1142658.
8
Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates.
Blood. 2007 Feb 15;109(4):1414-21. doi: 10.1182/blood-2006-03-010181. Epub 2006 Nov 7.
9
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
Nat Med. 2006 Mar;12(3):342-7. doi: 10.1038/nm1358. Epub 2006 Feb 12.
10
Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver.
Blood. 2006 Apr 1;107(7):2653-61. doi: 10.1182/blood-2005-10-4035. Epub 2005 Dec 1.
Zotero 插件